| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
909 |
659 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
24 |
17 |
$500.50 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
41 |
29 |
$409.64 |
| 99497 |
|
13 |
13 |
$405.36 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
33 |
19 |
$237.36 |
| 3078F |
|
245 |
214 |
$0.79 |
| 3074F |
|
184 |
160 |
$0.55 |
| 1125F |
|
142 |
128 |
$0.50 |
| 1126F |
|
40 |
35 |
$0.10 |
| 3075F |
|
12 |
12 |
$0.05 |
| 1159F |
|
295 |
255 |
$0.03 |
| 1160F |
|
295 |
255 |
$0.03 |
| 1101F |
|
225 |
197 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
13 |
12 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
13 |
12 |
$0.00 |